Hypercholesterolemia is a major risk factor for atherosclerosis. Remaining challenges in the management of atherosclerosis necessitate development of animal models that mimic human pathophysiology. We characterized a novel mutant pig model with DNA transposition of D374Y gain-of-function (GOF) cDNA of chimp proprotein convertase subtilisin/kexin type-9 (PCSK9), and tested the hypothesis that it would develop peripheral vascular remodeling and target organ injury in the kidney. Wild-type or PCSK9-GOF Ossabaw miniature pigs fed a standard or atherogenic diet (AD) (n = 7 each) were studied in vivo after 3 and 6 months of diet. Single-kidney hemodynamics and function were studied using multidetector computed tomography and kidney oxygenation by blood oxygen level-dependent magnetic resonance imaging. The renal artery was evaluated by intravascular ultrasound, aortic stiffness by multidetector computed tomography, and kidney stiffness by magnetic resonance elastography. Subsequent ex vivo studies included the renal artery endothelial function and morphology of abdominal aorta, renal, and femoral arteries by histology. Compared with wild type, PCSK9-GOF pigs had elevated cholesterol, triglyceride, and blood pressure levels at 3 and 6 months. Kidney stiffness increased in GOF groups, but aortic stiffness only in GOF-AD. Hypoxia, intrarenal fat deposition, oxidative stress, and fibrosis were observed in both GOF groups, whereas kidney function remained unchanged. Peripheral arteries in GOF groups showed medial thickening and development of atheromatous plaques. Renal endothelial function was impaired only in GOF-AD. Therefore, the PCSK9-GOF mutation induces rapid development of atherosclerosis in peripheral vessels of Ossabaw pigs, which is exacerbated by a high-cholesterol diet. This model may be useful for preclinical studies of atherosclerosis. 30 arterial pressure; HDL-C = high-density lipoprotein cholesterol; ROI = region of interest; RBF = renal blood flow; GFR = glomerular filtration rate; CTA = computed tomography angiography; MPR = multiplanar-reformatted; MRE = magnetic resonance elastography; VLDL-C = very low-density lipoprotein cholesterol
INTRODUCTION
Atherosclerosis is responsible for coronary and peripheral artery disease, which can remain asymptomatic for decades. 1 Despite advances in medical, interventional, and surgical treatment, atherosclerotic disease is still the leading cause of death in both developed and developing countries. 2 Animal studies have revealed fundamental mechanisms by which low-density lipoprotein cholesterol (LDL-C) causes atherosclerosis, but numerous challenges remain regarding optimal management and understanding of the disease. 3 Using animal models for understanding the pathophysiology of atherosclerosis and developing treatment or diagnostic strategies has proven somewhat challenging. Genetically modified mouse models have increased the understanding of the mechanisms and role of signaling pathways and genetic factors, which are important contributors to coronary artery disease and development of vascular disease. However, many models do not adequately replicate human disease, and their small size restricts clinically applicable intravascular interventions and noninvasive imaging. 4, 5 Additionally, many key features of human atherosclerosis are rarely seen, particularly development of peripheral vascular disease. These limitations necessitate development of novel models to assess atherosclerotic features and management, as well as validating new treatments and devices.
Pigs can develop spontaneous atherosclerosis, which similar to humans is accelerated by an atherogenic diet (AD), 6 ,7 yet in normal pigs the lesions are generally minimal. 8 However, recent progress in genetic engineering has paved the way for the creation of new models by genetic manipulations. Proprotein convertase subtilisin/ kexin type-9 (PCSK9) plays a key role in the clearance of LDL-C via its interaction with, and subsequent degradation of, LDL receptor (LDLR). 9 Following its discovery in 2003, a quest was started for both new gain of function (GOF) and loss-of-function mutations including D374Y PCSK9 and the heterozygote African nonsense C679X variants, respectively. 10, 11 GOF mutations result in greater binding of PCSK9 with LDL-R and increased LDL-C blood level. In addition to the PCSK9 enzyme, cholesteryl ester transfer protein (CETP), HMGCoA reductase, peroxisome proliferator-activated receptor-α protein, and microsomal triglyceride transfer protein play an important role in the metabolism of lipids. In particular, the PCSK9 and CETP genes are both regulated by the SREBP transcription factor family. 12, 13 CETP facilitates the transport of cholesteryl ester from high-density lipoprotein (HDL) to apolipoprotein B-containing lipoproteins, such as very low-density lipoprotein (VLDL) and LDL. CETP decreases the concentration of LDL-C and increases the concentration of HDL-C. PCSK9 may also affect plasma triglyceride via metabolism of VLDL-C and their remnants, 14 but this overall effect is considered modest. Yet given the rapid developments in PCSK9 inhibition, analogous PCSK9-related approaches might be discovered for inhibition of triglyceride as well. 15 Most of the genetically modified pig models have been developed by gene editing in porcine somatic cells followed by animal cloning. 16, 17 Al-Mashhadi et al. described development of hypercholesterolemia and atherosclerosis in PCSK9-GOF Yucatan minipigs. 18 Recently, we generated a novel D374Y human PCSK9-GOF Ossabaw pig model created by transposition of chimp DNA. Ossabaw pigs have the highest levels of total body lipid of any mammal even in the absence of a high-fat diet, and are naturally prone for spontaneous development of vascular disease. Furthermore, Ossabaw pigs fed a highfat cholesterol diet develop hypertriglyceridemia and increased LDL-to-HDL cholesterol ratio, mild hypertension, and coronary artery disease. 19 Therefore,
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Background
Using large animal models for atherosclerosis research has proven relatively challenging. We generated a novel PCSK9-gain-of-function (GOF) transgenic pig model on the Ossabaw background. This model exhibits peripheral arterial disease involving the renal artery, femoral artery, and aorta, which is exacerbated by an atherogenic diet. This is reflected in development of early atherosclerotic plaques, aortic stiffening, and development of hypertension. In the kidney, we observed intrarenal fat deposition, increased oxidative stress, apoptosis, hypoxia, endothelial dysfunction and mild fibrosis.
Translational Significance
This study suggests that the PCSK9-GOF model may be useful as a preclinical platform to study atherosclerotic peripheral artery disease.
a combination of the Ossabaw pig genetic background with PCSK9-GOF could constitute a particularly promising model for vascular translational research. The kidney is a common target organ in cardiovascular disease. Atherosclerotic changes in the renal artery are evident in 50% of patients with atherosclerotic disease elsewhere. 20 In addition to vascular remodeling, a growing body of evidence suggests that atherosclerosis has direct effects on the kidney, eliciting intrarenal microvascular and glomerular disease, positioning the kidney as an important target organ in peripheral vascular disease. 21 In the present study, we characterized the PCSK9 Ossabaw pig model and tested the hypothesis that pigs with PCSK9-GOF mutation fed with a high-fat diet would develop peripheral vascular remodeling and renal injury.
MATERIALS AND METHODS
Study protocols. This study was approved by the Mayo Clinic Institutional Animal Care and Use Committee. Twenty-one 3-month-old female Ossabaw pigs (Recombinetics Inc., St. Paul, MN) were studied in 3 groups (n = 7 each), including wild-type (WT), fed a normal diet (ND), PCSK9-GOF fed ND, and PCSK9-GOF fed an AD, all for 6 months. The AD diet was fed ad libitum (Agri-Nutrition Services, Inc., Shakopee, MN) and contains approximately 19.8% fat (ether extract, with 2% cholesterol), 17% protein, 5.3% fiber, and 41.8% carbohydrate (nitrogen-free extract by subtraction), with an estimated total average daily consumption of 6200 kcal (1020 kcal protein, 2674 kcal fat, and 2506 kcal carbohydrates).
At baseline, the animals were also implanted with a PhysioTel telemetry transmitter (DSI, St. Paul, MN) for measurements of blood pressure. In vivo imaging studies were performed after 3 months and repeated after 6 months of diet. For in vivo studies, pigs were anesthetized, and 8F sheaths were placed in the jugular vein and artery to collect blood for lipid levels. Kidney function was quantified using multidetector computed tomography (MDCT) and the renal artery plaque volume (PV) by intravascular ultrasound (IVUS). Renal oxygenation was assessed in vivo by blood oxygen level-dependent magnetic resonance imaging (BOLD-MRI), renal stiffness by magnetic resonance elastography (MRE), and aortic distensibility evaluated by MDCT.
After the last 6-month in vivo study, the animals were allowed a 3-day recovery period, and were subsequently euthanized by a lethal intravenous dose of pentobarbital (Fatal-Plus solution, 100 mg/kg, Vortech, Dearborn, MI). The kidneys were removed, and sections were frozen in liquid nitrogen (and maintained at −80°C) or preserved in formalin for in vitro studies. In addition, kidney samples were prepared for microvascular architecture assessment with micro-CT. Histology sections were stained with Picro-sirius red, ox-LDL, OilRed-O, terminal deoxynucleotidyl transferase dUTP nickend labeling (TUNEL), and dihydroethidium (DHE), and examined by light microscopy to quantify fibrosis, fat deposition, apoptosis, and oxidative stress in the kidney. 22 Renal arteries were dissected to assess endothelial function, and the lower abdominal aorta, renal, and femoral arteries were isolated and stained with hematoxylineosin (H&E), trichrome, Sirius-Red, Movat, CD107a, and E06 to examine their morphology inflammatory infiltrates, and media-to-lumen ratio ex vivo.
To distinguish the effect of GOF on PCSK9 and lipid levels from that of the AD alone, systemic in vivo data were collected from 3 additional WT pigs after a 6-month AD.
Systemic measurements. Mean arterial pressure (MAP) was measured as the average of the last 48 hours recorded by telemetry before each in vivo study. Heart rate was monitored and recorded during MRI and MDCT studies. Levels of total cholesterol, triglycerides, LDL-C, and HDL-C were determined by standard procedures. VLDL-C was approximated as triglyceride/5 based on the Friedewald formula, for our samples with triglyceride levels <400 mg/mL. 23 PCKS9 plasma levels were measured by enzyme-linked immunosorbent assay (R&D, Minneapolis, MN). Urine was collected via bladder puncture to determine albumin excretion, and blood from the inferior vena cava for creatinine levels following standard procedures.
PCSK9 GOF model characterization. The primate coding sequence for PCSK9 that is 99% identical to Homo sapiens was introduced into male Ossabaw fibroblasts, 24 containing the mutation causing D374Y substitution. Transgenic cells were used for cloning to generate a transgenic Ossabaw founder line. Expression of PCSK9-D374Y transcript in these animals is directed by a liverspecific promoter to control PCSK9 expression to the liver, the primary endogenous source.
25
In vivo studies. Each in vivo study consisted of MRI followed by MDCT studies 2-3 days later. For each study, animals were weighed and then induced with 0.5 mg intramuscular ketamine and xylazine, intubated, and ventilated with room air. During MDCT, anesthesia was maintained with intravenous ketamine (0.2 mg/kg per minute) and xylazine (0.03 mg/kg per minute) and during MRI using isoflurane (1%-2%) inhalation.
BOLD-MRI. To assess intrarenal oxygenation, BOLD-MRI was performed at 3T (Signa EXCITE, GE Healthcare, Waukesha, WI) using a spoiled gradient echo sequence as described previously. 26, 27 R2*, an index of deoxyhemoglobin concentration in cortical and medullary regions of the kidney, was quantified using an in-house developed MatLab software (MatLab 7.10, The MathWorks, Natick, MA). All scans were performed during breath-hold and regions of interest (ROI) manually traced in the cortex and medulla on the 7-ms echo time images to compute the average of MR signals within each ROI, and calculate R2*.
MDCT. MDCT (Somatom Definition-128, Siemens Medical Solution, Forchheim, Germany) scanning was performed to assess kidney volume, renal blood flow (RBF), and glomerular filtration rate (GFR), as described previously, 28, 29 following a central venous injection of iopamidol (0.5 mL/kg/2 seconds). MDCT images were reconstructed and displayed on the Analyze software package (Biomedical Imaging Resource, Mayo Clinic, Rochester, MN). For functional data analysis, ROIs were selected from cross-sectional kidney images to generate time-attenuation curves and obtain measures of renal function. RBF was measured as the sum of the products of cortical and medullary perfusions and volumes, whereas GFR was calculated from the cortical curve using the slope of the proximal tubular curve. A separate cardiac scan was used to measure cardiac output 28 for calculation of systemic vascular resistance (SVR) as 80 × MAP/ cardiac output.
Computed tomography angiography. Computed tomography angiography (CTA) images of the renal artery were obtained using MDCT. Renal volume study was performed after a 15-minute rest in the helical mode (240 mAs, 120 kV, pitch of 1.2, and B40 medium kernel) to obtain contiguous 5-mm-thick slices for measurements of cortical, medullary, and total kidney volume.
For CTA, the volume data was reconstructed at a resolution of 0.39 × 0.39 mm, and 0.6-mm slice thickness with 0.3-mm overlap. 30 Automated quantification of diameter stenosis was acquired. A fast vessel-tracking algorithm was performed to acquire a 3-dimensional centerline of the renal artery and a stretched multiplanarreformatted (MPR) volume created from the segment of interest, to allow studying the curved renal arteries as straight vessels. MPR volume-derived longitudinal and transverse outlines, detected by an initial approximation of the lumen border locations, were established by an automatic algorithm, with only limited manual input used to refine the automated processing steps. Then the lumen border outlines were detected in each transversal slice of the MPR volume with a circular lumen model. During this step, the intersection points of each transversal slice with the earlier obtained longitudinal outlines were used to guide the outline detection in each particular slice. Based on the cross-sectional area of the obtained transversal outlines, a diameter function along the vessel course was derived using the formula for circular cross sections. 31 Lastly, from these data, the reference diameter function, minimal lumen diameter, and degree of stenosis were obtained.
MRE. MRE scanning was performed during 30-second breath-hold to assess medullary fibrosis in vivo, as described previously. 32 We have shown that medullary stiffness provides a more reliable index of kidney fibrosis than cortical stiffness. 32 Briefly, pigs were placed on their backs, and a 3D stack of images was collected using echo-planar imaging in conjunction with motionsensitizing gradients placed on the animal's dorsal surface, proximal to the kidneys. Images were analyzed using MRE/Wave (MRI Research Lab, Mayo Clinic, Rochester, MN). Measurements of tissue displacement were used to derive shear modulus. Stiffness values were averaged within ROIs, manually traced around the renal medulla on the echo-planar imaging magnitude images, and verified with the aid of co-registered contrastenhanced MDCT images.
IVUS. After intravascular administration of 0.1 mg/ mL nitroglycerin, IVUS was performed using a 20 MHz IVUS catheter (Eagle Eye Gold, Volcano, Rancho Cordova, CA) that was inserted into the renal artery with an automatic pullback system (0.5 mm/s). All images underwent a randomized, double-blind, offline volumetric reconstruction analysis (Volcano Image Analysis software V3.1) by an experienced evaluator. The quantitative volumetric analysis was completed in 20-mm segments from the ostium of the renal artery. The average vessel volume (mm 3 ) was computed by average vessel area (mm 2 ) × 20-mm segment. When plaques were identified, PV percentage (%PV) was calculated by PV/ average vessel volume × 100. The change in %PV from the 3 months to 6 months was determined as delta %PV (D%PV).
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Aortic distensibility. Cross-sectional MDCT images of the aorta were displayed with Analyze, and 5 consecutive slices at both the systolic and the diastolic phases were traced. Subsequently, the average surface areas of the aorta at systole and diastole were calculated, and its distensibility (mm Hg −1 ) was assessed as (maximum change in area/minimum area × [systolic blood pressurediastolic blood pressure]). 34 
Ex vivo studies.
Micro-CT. After the kidney was flushed, microfil MV122 (an intravascular contrast agent) was perfused into the kidney under physiological pressure through a cannula ligated in the renal artery. Samples were prepared and scanned at 0.5°angular increments at 20-µm resolution. The spatial density of microvessels (diameters <500 µm) in the renal cortex was calculated using Analyze and classified as small (20-40 µm), medium (40-200 µm), or large (200-500 µm) microvessels. 35 Furthermore, the 3D nature of the micro-CT dataset allows calculations of vessel tortuosity, an index of vascular maturity. Specifically, the 3-dimensional vascular path length (actual length) and linear length (the shortest distance from base to tip) were determined from the base of the main vessel at the corticomedullary junction to its tip at the superficial cortex. Tortuosity index was analyzed by dividing the path length by the linear length.
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Vascular histology. Segments of vessels were dissected from comparable topographic locations in the abdominal aorta, renal artery, and femoral artery of each animal, and 5-mm sections stained with H&E, trichrome, Sirius-Red, CD107a, E06, CD31, von Kossa, α-SMA, and Movat pentachrome, and examined by light microscopy for the presence of atherosclerotic plaques. The media and lumen cross-sectional areas of each vessel were traced (Analyze), and their ratio in each vessel was averaged for each group. 37 In addition, sections of the aorta were digitalized for histomorphometry of the lesions, including the lesion area and tunica media, using the Analyze analysis software. The normalized plaque area, expressed as the ratio of the lesion to medial areas, was used to adjust and compare arteries of different sizes. 38 Plaque area was calculated using slides stained for elastin and collagen.
Renal histology. Kidney fibrosis was examined by Picrosirius red, fat deposition by Oil-red-O, and oxidative stress by OX-LDL staining in 5-µm paraffin embedded midhilar renal cross sections. The histochemical analysis used a computer-aided image-analysis program (AxioVision, Carl Zeiss MicroImaging, Thornwood, NY). Staining was semiautomatically quantified in 10-15 fields in each slide, expressed as the fraction of kidney surface area, and the results from all fields were averaged. 22 In situ renal production of superoxide anion was evaluated by fluorescence microscopy after DHE staining and apoptosis by TUNEL. Tubular injury was scored on a 1-5 scale (1: <10%, 2: 10%-25%, 3: 26%-50%, 4: 51%-75%, and 5: >75% injury) in 40 × H&E slides, based on tubular dilation, atrophy, cast formation, sloughing tubular cells, or basement membrane thickening.
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Renal arterial endothelial function. Renal artery segments were placed in Krebs solution, and sections (n = 8/ pig, 7 pigs/group) were mounted in individual organ chambers (1 per renal artery ring), attached to an isometric force transducer with continuous recording, and contracted using potassium chloride (20 mM). 40 Endothelium functionality was confirmed by the response to acetylcholine (Ach) (1 × 10 −6 M), and vessel rings were allowed to equilibrate for 30 minutes. Following precontraction with endothelin-1 (10 −7 M), incremental concentrations of Ach (10 M) were administered to evaluate endothelium-dependent relaxation, and endothelium-independent vasodilation with sodium nitroprusside (10 M), respectively. Statistical analysis. Statistical analysis was performed using JMP software package version 11.0 (SAS Institute, Cary, NC). Results were expressed as mean ± SEM for normally distributed variables or median (range) for non-Gaussian distributed data. Comparisons within groups were performed using analysis of variance followed by paired Student t test and among groups using unpaired t test or nonparametric (Wilcoxon followed by KruskalWallis) tests when appropriate. P ≤ 0.05 was considered statistically significant. Table I shows the characteristics of the animals included in the study. All groups significantly increased body weight at 6 months, with WT-AD being the heaviest. Body weight was lower in GOF compared with WT pigs, likely because they were the first generation after cloning. MAP was increased in both GOF groups at 3 and 6 months, but not in WT-AD. SVR, total serum cholesterol, LDL-C, VLDL-C, and triglycerides levels also rose in GOF-ND and GOF-AD compared with WT, whereas HDL-C was elevated only in GOF-AD at 6 months. LDL-C level at 3 months was 12-fold and 24-fold higher in PCSK9-ND and PCSK9-AD, respectively, compared with WT, and 13-fold and 29 times higher at 6 months (P < 0.05). Albumin-to-creatinine ratio remained unchanged among the groups. The levels of PCSK9 after a 6-month diet were similarly elevated in the GOF-ND and GOF-AD compared with the WT-ND and WT-AD (P < 0.05, Table I), confirming the success of the mutation. Notably, LDL-C and PCSK9 levels correlated well (Fig 1, E) . Triglyceride levels were nearly 2-fold higher in PCSK9 groups compared with WT, at 3 months and 6 months. In WT-AD, lipid levels were elevated compared with WT-ND, but total and LDL-C remained markedly lower than in GOF-ND, although their triglyceride and VLDL-C levels were higher. Table II shows a summary of the directional changes in parameters in GOF compared with WT-ND pigs during the course of the diet.
RESULTS
Renal vascular studies. Average renal artery diameter in vivo by CTA was smaller in both GOF groups compared with WT-ND at both the 3-month and 6-month studies (Fig 1, A) . In vivo IVUS data are presented in Fig 1, B . Vessel volume and PV at 3 months tended to be higher in GOF-AD than in GOF-ND and WT, but only vessel volume at 6 months was significantly higher than in GOF-ND. Both GOF groups showed a significant increase in renal artery PV from 3 to 6 months of diet, with no change over time in vessel volume or %PV. At 6 months, arterial wall thickening (increased media-tolumen ratio) was evident ex vivo in the renal artery in GOF-AD. Furthermore, neointimal hyperplasia was evident in the renal artery in GOF-AD, but not in WT and GOF-ND. GOF-AD demonstrated a more diffuse intima-media thickening in the renal artery compared with GOF-ND and WT (Fig 1, C) . The isolated renal artery vasorelaxation response to Ach was attenuated in GOF-AD but not in GOF-ND, whereas the response to sodium nitroprusside was unchanged (Fig 1, D) .
Renal hemodynamics, function, and oxygenation.
Single-kidney cortical and medullary perfusion, RBF, and GFR were not different among the groups at either time point (Table I) . Renal cortical and medullary R2* was higher in GOF-AD than in WT and GOF-ND at 3 months, but became elevated in both groups at 6 months, suggesting decreased oxygenation in transgenic PCSK9 groups (Fig 2, A) . MRE showed no difference in medullary stiffness among the groups at 3 months, but an increase in both GOF groups by 6 months (Fig 2, B) . The spatial density of small-, medium-, and large-sized cortical microvessels was increased in both GOF groups, whereas microvascular tortuosity was unchanged (Fig 2, C) . Picro-sirius red staining showed significantly greater cortical and medullary fibrosis in the GOF groups compared with WT (Fig 3, A) , and tubular injury score was increased (Table I) . Oil-Red-O staining showed greater fat accumulations in GOF-AD compared with WT and GOF-ND, whereas E06 increased in both GOF groups (Fig 3,  B) . DHE staining, an index of tissue oxidative stress, was also elevated in both GOF groups compared with WT (Fig 3, C) , and the TUNEL assay revealed a significant increase in the number of apoptotic cells (Fig 3, D) .
Aortic studies. Aortic distensibility, a CT-derived parameter of early structural wall changes, remained unchanged at 3 months but significantly decreased in GOF-AD compared with WT and GOF-ND (Fig 4, A) at 6 months. The sites of ex vivo vascular sample collection are illustrated in Fig 4. Arterial wall thickening was observed ex vivo in the GOF aorta at 6 months. Furthermore, the aorta showed eccentric fibrofatty plaque with intimal thickening and fatty streaks in GOF groups, whereas WT showed unremarkable morphology (Fig 4,  B) . GOF-AD demonstrated a more diffuse intimamedia thickening in the aorta compared with GOF-ND and WT. However, although the normalized lesion area in the inferior aorta appeared to be slightly increased in GOF groups by histomorphometry, this has not reached statistical significance levels (Fig 4, D) .
Femoral artery studies. At 6 months, arterial wall thickening was evident ex vivo in the femoral artery. In addition, the femoral artery showed eccentric fibrofatty plaque with intimal thickening and fatty streaks in both GOF groups, but not in WT (Fig 5) . The lesions in WT animals were consistent with minimal to mild neointimal thickening, consisting mainly of smooth muscle cells and proteoglycans and rare foam cells, whereas GOF-ND and GOF AD generally showed minimal to mild fibrofatty or fibroatheromatous plaques accompanied by necrosis with an overlying fibrous cap, and complications of intimal calcification (speckled to dense).
DISCUSSION
Our study demonstrates that PCSK9-GOF in Ossabaw minipigs induces peripheral arterial disease involving the renal artery, femoral artery, and aorta, which is exacerbated by superimposition of an AD. This is reflected in development of early atherosclerotic plaques in the peripheral vessels, aortic stiffening, and development of hypertension. In the kidney, we observed intrarenal fat deposition, increased oxidative stress, apoptosis, hypoxia, endothelial dysfunction, and mild fibrosis, which are consistent with the effects of early atherosclerosis and 
Abbreviations: GFR, glomerular filtration rate; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; MAP, mean arterial pressure; MRE, magnetic resonance elastography; RBF, renal blood flow. *P < 0.05 vs WT.
Fig 2. (A)
Single-kidney BOLD-MRI illustrating hypoxic regions (yellow-red). R2* in the cortex and medulla increased in GOF-AD by 3 months on diet, and in GOF-ND by 6 months (n = 7/group). (B) MRE showed in vivo elevated renal medullary stiffness (yellow-red) at 6 months in both GOF groups (n = 5/group). (C) Representative 3-dimensional micro-CT images of kidney segments and quantification of renal microvascular spatial density and tortuosity, showing an increase in the microvascular density in GOF groups' unchanged tortuosity. *P < 0.05 vs WT; †P < 0.05 vs GOF-ND. AD, atherogenic diet; BOLD, blood oxygen level-dependent; GOF, gain of function; MRE, magnetic resonance elastography; MRI, magnetic resonance imaging; ND, normal diet; WT, wild-type. (Color version of figure is available online.)
hypercholesterolemia on renal injury. Therefore, this study suggests that PCSK9-GOF model may be useful as a preclinical platform to study atherosclerotic peripheral artery disease.
An important hurdle to current studies of atherogenesis is the lack of large animal models to investigate the progression and mechanisms of the disease process. The mouse, hamster, rat, and rabbit models are useful animal (C) Renal production of superoxide anion (DHE, magenta) and (D) apoptosis (TUNEL, cyan) increased in both GOF-ND and GOF-AD (n = 7/group). *P < 0.05 vs WT; †P < 0.05 vs GOF-ND. AD, atherogenic diet; GOF, gain of function; LDL, low-density lipoprotein; ND, normal diet; TUNEL, terminal deoxynucleotidyl transferase dUTP nick-end labeling. (Color version of figure is available online.) models of atherosclerosis, 4, 5, 41 yet pigs show many genetic, anatomic, and physiological similarities to humans, which allow using clinically applicable medical devices and treatments, and collecting sufficient blood and tissue samples for analysis.
Several breeds of swine are widely used for preclinical evaluation of safety and efficacy of medical interventions. Previous studies have shown that transgenic Yucatan minipigs expressing human, liver-specific D374Y-PCSK9 and fed an AD for approximately 1 year, demonstrated increased cholesterol (to 772 mg/dL) and LDL-C (to 425 mg/dL) levels. 18 Similarly, cholesterol levels increase in diabetic or hypercholesterolemic, Rapacz familial hypercholesterolemic, domestic, Ossabaw, and LDLR knockout domestic and Yucatan pig models, but to lower levels than those achieved in this model after a 3-month diet. [42] [43] [44] [45] Some pig models are limited by a big body size, difficulty of triggering atherosclerotic lesions, or a prolonged induction period. Accelerating atherosclerosis in healthy pigs is difficult, 46, 47 and often necessitates feeding with high fat or other atherosclerosisaccelerating procedures, such as balloon injury or streptozotocin-induced diabetes. [48] [49] [50] Additional drawbacks of some pig models might be a broad genetic background and the nature of the mutation, as well as the diversity secondary to the efforts to miniaturize the pig by crossing with smaller pig breeds. The balloon injury intervention, although useful, has yet to fully mimic the natural occurrence of atherosclerosis and realistic response to applied treatments and devices. The occurrence of atherosclerosis following balloon injury has yet to be evaluated in the Ossabaw PCSK9-GOF model. PCSK9, a member of the proprotein convertase family, is a secretory protein that regulates LDLR after transcription, primarily via degradation of the hepatic LDLR. PCSK9 is expressed in the liver and to a lesser extent in the intestine, kidneys, 51 as well as in human atherosclerotic plaques. PCSK9 binds hepatic LDLRs, directing -1) , (G) von Kossa (calcium), (H) and α-smooth muscle cell actin (α-SMA), showed increased staining in GOF-ND and GOF-AD (n = 7/group). The higher power magnifications H&E and von Kossa represent regions corresponding to the red box in the low-power Movat pentachrome stain. The minimal lesions in the WT mainly consisted of smooth muscle cells and neointimal hyperplasia. Contrarily, fibroatheromatous plaques with oxidized LDL accumulation were noted in GOF-ND and GOF-AD. *P < 0.05 vs WT. AD, atherogenic diet; GOF, gain of function; H&E, hematoxylin-eosin; LDL, low-density lipoprotein; ND, normal diet. (Color version of figure is available online.) them to lysosomal degradation, and is a crucial regulator of LDL-C levels. 52 Human D374Y-PCSK9 binds the porcine LDLR with high affinity. 18 The GOF D374Y upturns affinity of this binding, which causes a severe form of autosomal dominant hypercholesterolemia in humans. 53 The LDLR residues demonstrated to be critical for binding of human D374Y-PCSK9. 54 Previous studies have shown that the pathologic effect of PCSK9-GOF occurs primarily through an increase in the level of LDL-C, 18 but it may also have a local effect in the vascular wall, which may be independent of its effect on systemic cholesterol levels. 55, 56 Its effect on triglyceride and HDL-C levels is more modest, and is somewhat independent of LDLR. For example, PCSK9 enhances intestinal overproduction of triglyceride-rich lipoproteins through both LDLR-dependent and -independent mechanisms. 14, 53, 57 One of the novel aspects of our model is the imposition of a PCSK9-GOF mutation on the genetic background of Ossabaw minipigs. Consequent to natural selection, WT Ossabaw pigs are inherently prone to dyslipidemia and mild atherosclerotic lesions, especially when fed a high-fat diet, but their development may take months. 19 Our study demonstrates that a PCSK9-GOF mutation in Ossabaw pig produces a promising model for translational vascular research. Ossabaw PCSK9-GOF pigs have a compact body size, a wellcharacterized background, and lesion formation within a relatively short time. In the current study, we found that ectopic expression of PCSK9-D374Y in Ossabaw pigs significantly elevated systemic levels of PCSK9. The elevated levels of PCSK9 in the GOF-ND group in the face of low levels in WT-AD pigs are consistent with rise in PCSK9 resulting from the mutation, rather than from the AD alone. Indeed, PCSK9-GOF in pigs fed ND markedly aggravated dyslipidemia compared with WT pigs fed AD, although the higher triglycerides and VLDL-C levels in WT-AD remain to be clarified.
Furthermore, PCSK9-GOF induced kidney vascular remodeling as early as 3 months after initiation of ND (6 months of age). Superimposition of AD exacerbated development of early atherosclerosis lesions in peripheral arteries, renal arterial remodeling, endothelial dysfunction, and aortic stiffness, possibly because of almost doubling of serum cholesterol levels. These findings suggest that the predominant effect of PCSK9-GOF mutation on peripheral vascular disease and target organ injury in this model are attainable without, but can be markedly amplified by, a high-fat diet. Interestingly, we observed an increase in blood pressure in both GOF groups. This might be because of higher SVR secondary to vascular remodeling and vasoconstriction imposed by elevated cholesterol levels, but also to possible involvement of some PCSK9 variants in regulation of blood pressure, 58 as well as the sympathetic nervous system hyperactivity. 59 The observation that blood pressure was elevated in GOF-ND and GOF-AD, but not in WT-AD pigs, supports the role of PCSK9 and elevated cholesterol levels in development of hypertension in our model.
The mechanism underlying vascular remodeling (wall thickening, plaque development, changes in microvascular architecture, etc.) in our model likely involves an increase in plasma and tissue LDL-C concentration, which may in turn decrease release of nitric oxide and accelerate endothelial apoptosis and dysfunction, vascular smooth muscle cell proliferation, as well as formation of atherosclerotic plaques. 60 Indeed, we observed in GOF groups an increase in media-to-lumen ratio in peripheral vessels with early plaques and intimal thickening. Yet a slight increase in the plaque area in the GOF groups by histomorphometry has not reached statistical significance levels because of high variability, possibly because subjective elements in histomorphometry measurements might be accentuated in mild atherosclerotic lesions. 61 We also observed endothelial dysfunction only in the GOF-AD renal artery, indicating acceleration of vascular dysfunction by the high-fat diet. Possibly, a certain threshold of levels (and likely also duration) of hypercholesterolemia may account for the magnified effect on renal arterial endothelial function in GOF-AD. Yet both GOF groups developed ex vivo positive remodeling of peripheral vessels, a common feature of human-like atherosclerotic lesions that can reduce the elasticity of the artery walls and are commonly initiated by endothelial injury and dysfunction. 62 Although organ bath studies were not performed on other vessels, aortic distensibility was also significantly decreased in GOF-AD, indicating the impact of the diet.
The aorta and femoral artery showed eccentric fibrofatty plaque with intimal thickening and fatty streaks, whereas the atherosclerotic structural changes in the renal artery were milder, and consisted mainly of arterial wall thickening. Presumably, the renal artery might be less susceptible to the functional and structural effects of AD, and changes take longer to become measurable. IVUS studies in the renal artery showed a rise in PV in both GOF groups over the course of the study. Compared with 3 months' data, the 6 months' %PV and vessel volume appeared to be slightly increased (albeit not significantly), whereas the significantly increased PV likely reflects initiation of positive remodeling and progression of atherosclerosis, which may have contributed to the increases in arterial stiffness and blood pressure. Yet the difference in %PV and PV by IVUS was not significantly different between WT and GOF-ND. Indeed, because the Ossabaw pig strain is prone to spontaneous vascular pathology, the WT pigs showed mild renal artery remodeling; very high cholesterol levels, as those achieved in GOF-AD, may be required to increase vascular remodeling even further.
Most of the renal arteries in GOF pigs, particularly GOF-AD, were characterized by medial hypertrophy, possibly partly because of the mild hypertension that both GOF groups developed. Medial area in IVUS analysis is often included in the "plaque area" measurements, which are derived by subtracting the lumen area from external elastic membrane area (Fig 1) . This approach results in a slight overestimation of atheroma area (in comparison with histology) by including the media, and may have led to a slight discrepancy between IVUS and histology. 63 The functional significance of aortic remodeling is underscored by its decreased elasticity, a common pathologic mechanism that results in development and progression of vascular disease and hypertension.
The elevated renal DHE and TUNEL staining in the GOF groups indicate renal oxidative stress and apoptosis, respectively, possibly because of accumulation of ox-LDL and development of endothelial dysfunction, which may, in turn, lead to kidney hypoxia and tubular injury. Notably, E06 staining may react with apoptotic cells and may reflect the degree of apoptosis, rather than ox-LDL levels. 64 Given that PCSK9 promotes ox-LDLinduced apoptosis. 65 As we have shown before in models of hypercholesterolemia, 66 we observed microvascular remodeling reflected in an increase in the cortical vascular density in GOF pigs, probably because of oxidative stress and inflammation. As opposed to arterial lesions, microvascular density was similarly increased in both GOF group, suggesting that alterations in microvascular architecture precede or require a lower cholesterol levels than macrovascular remodeling. Newly formed microvessels sustain cortical and medullary perfusion and function in this noxious milieu. Nevertheless, increased oxidative stress and inefficient oxygen utilization may result in hypoxia and fibrosis. 67 Interestingly, these changes were similar in GOF-ND and GOF-AD groups, suggesting that cholesterol levels prevailing in this model when fed a standard diet suffice to induce subtle renal injury.
Limitations. The study is limited by use of relatively young animals and short diet duration, yet this model recapitulates many features of atherosclerosis in humans. The Ossabaw pig strain that constitutes our WT group is naturally prone to development of vascular lesions, which likely attenuated observed differences among the groups. As a result, differences by IVUS and by histology were modest in the PCSK9 GOF groups compared with WT. Interestingly, we also observed subtle differences between the GOF-ND and the GOF-AD groups, perhaps because of short duration of diet, implying that an AD is not mandatory to produce some features of early atherosclerosis in this model, although it does aggravate them. Unaltered kidney function, normal albumin-to-creatinine ratio, and mild tubular injury, imply a relatively minor damage to the kidney parenchyma. Furthermore, longer observation periods or injury may be needed to detect obstructive atherosclerotic lesions and deterioration in renal function. Most of the effects of PCSK9 are likely mediated via LDLR in the liver; we cannot rule out the possibility of a minor direct effect in our study.
Although we attempted to be consistent in sample collection sites, there might have been some variability among animals; hence, we normalized media to luminal cross-sectional areas. Furthermore, sampling 5-µm slides ex vivo (histology) vs 2 cm (IVUS) or the entire renal artery (CTA) may have contributed to slightly different observations made using these modalities.
CONCLUSION
In the current study, we observed in a novel Ossabaw D374Y PCSK9-GOF model prominent hypercholesterolemia, renal arterial endothelial dysfunction, peripheral vascular remodeling, and spontaneous development of early atherosclerotic lesions by the time the pigs reached 9 months of age. We also found clear evidence of early kidney injury, although its function remained intact. This model, therefore, shows many similarities to human peripheral artery disease and may provide a useful tool for translational research and to assess atherosclerotic features and management.
